glp 1 egfr cut off GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and #obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read KDOQI Commentary on the KDIGO
Description
PBPK, physiologically based pharmacokinetics
Understanding your peptide pathway genetics also reveals whether you might respond better to semaglutide injection (starting at $149/month), oral semaglutide, or dual-compound options like GLP-Squared, which combines semaglutide and tirzepatide in a single medication
A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes and obesity, may also lower the risk of dangerous blood clots
doi: 10.1126/sciadv.1500183 28 CoyleC.CaffertyF
Baviera M, Foresta A, Colacioppo P, Macaluso G, Roncaglioni MC, Tettamanti M, Fortino I, Genovese S, Caruso I, Giorgino F
